Expression of soluble proteins in Escherichia coli by linkage with the acidic propiece of eosinophil major basic protein

Protein Expression and Purification

Volumn 79, Issue 1, 2011, Pages 72-80

  DiScipio, Richard G ^a   Khaldoyanidi, Sophia K ^a   Schraufstatter, Ingrid U ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

C5a; CCL18; Complement; FGF ; Inclusion bodies; LIF; Protein expression; Recombinant cationic proteins; Solubility enhancement; Stem cells

Indexed keywords

BETA CHEMOKINE; COMPLEMENT COMPONENT C5A; FIBROBLAST GROWTH FACTOR; HYBRID PROTEIN; LEUKEMIA INHIBITORY FACTOR; MAJOR BASIC PROTEIN;

ARTICLE; CELL STRAIN HEK293; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MOLECULAR CLONING; SOLUBILITY;

CHEMOKINES, CC; CLONING, MOLECULAR; COMPLEMENT C5A; EOSINOPHIL MAJOR BASIC PROTEIN; ESCHERICHIA COLI; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION; HEK293 CELLS; HUMANS; LEUKEMIA INHIBITORY FACTOR; RECOMBINANT FUSION PROTEINS; SOLUBILITY;

ESCHERICHIA COLI;

EID: 79960148754     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2011.04.016     Document Type: Article

References (60)

1. F. Baneyx, and M. Mujacic Recombinant protein folding and misfolding in Escherichia coli Nat. Biotechnol. 22 2004 1399 1408
2. K.W. Mollison, T.A. Fey, R.A. Krause, W. Madnecki, J.L. Fox, and G.W. Carter High level C5a gene expression and recovery of recombinant C5a from Escherichia coli Agents Actions 21 1987 366 370
3. I. Palmer, and P.T. Wingfield Preparation and extraction of insoluble (inclusion-body) proteins from Escherichia coli Curr. Protoc. Protein Sci. Chapter 6 2004 unit 6.3
4. L.D. Cabrita, and S.P. Bottomley Protein expression and refolding - A practical guide to getting the most out of inclusion bodies Biotechnol. Annu. Rev. 10 2004 31 50 (Pubitemid 39419988)
5. A. Mukhopadhyay Inclusion bodies and purification of proteins in biologically active forms Adv. Biochem. Eng. Biotechnol. 56 1997 61 109
6. S.M. Singh, and A.K. Panda Solubilization and refolding of bacterial inclusion body proteins J. Biosci. Bioeng. 99 2005 303 310 (Pubitemid 40740579)
7. G. Georgiou, and P. Valax Expression of correctly folded proteins in Escherichia coli Curr. Opin. Biotechnol. 7 1996 190 197 (Pubitemid 26124077)
8. J.T. Moore, A. Uppal, F. Maley, and G.F. Maley Overcoming inclusion body formation in a high-level expression system Protein Expr. Purif. 4 1993 160 163
9. D.F. Carney, and T.E. Hugli Site-specific mutations in the N-terminal region of human C5a that affect interactions of C5a with the neutrophil C5a receptor Protein Sci. 2 1993 1391 1399 (Pubitemid 23262832)
10. S. Ventura, and A. Villaverde Protein quality in bacterial inclusion bodies Trends Biotechnol. 24 2006 179 185
11. D. Sachdev, and J.M. Chirgwin Fusions to maltose-binding protein: control of folding and solubility in protein purification Methods Enzymol. 326 2000 312 321
12. D. Sachdev, and J.M. Chirgwin Solubility of protein isolated from inclusion bodies is enhanced by fusion to maltose-binding protein or thioredoxin Protein Expr. Purif. 12 1998 122 132 (Pubitemid 28361978)
13. E.K. Lee, J.H. Hwang, D.Y. Shin, D.I. Kim, and Y.J. Yoo Production of recombinant amyloid-beta peptide 42 as an ubiquitin extension Protein Expr. Purif. 40 2005 183 189 (Pubitemid 40240986)
14. D.B. Smith, and K.S. Johnson Single step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase Gene 67 1988 31 40
15. M.R. Razeghifard On-column refolding of recombinant human interleukin-4 from inclusion bodies Protein Expr. Purif. 37 2004 180 186 (Pubitemid 39027258)
16. T. Ouellette, S. Destrau, T. Ouellette, J. Zhu, J.M. Roach, J.D. Coffman, T. Hecht, J.E. Lynch, and S.L. Giardina Production and purification of refolded recombinant human IL-7 from inclusion bodies Protein Expr. Purif. 30 2003 156 166 (Pubitemid 36990327)
17. E.Z. Eisenmesser, R.B. Kapust, J.P. Nawrocki, M.J. Mazzulla, L.K. Pannell, D.S. Waugh, and R.A. Byrd Expression, purification, refolding, and characterization of recombinant human interleukin-13: utilization of intracellular processing Protein Expr. Purif. 20 2000 186 195
18. R. Asano, T. Kudo, K. Makabe, K. Tsumoto, and I. Kumagai Antitumor activity of interleukin-21 prepared by novel refolding procedure from inclusion bodies expressed in Escherichia coli FEBS Lett. 528 2002 70 76 (Pubitemid 35258002)
19. U. Rinas, F. Hoffmann, E. Betiku, D. Estapé, and S. Marten Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli J. Biotechnol. 127 2007 244 257 (Pubitemid 46107138)
20. L.F. Vallejo, and U. Rinas Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration Biotechnol. Bioeng. 85 2004 601 609 (Pubitemid 38270492)
21. B. Klösch, W. Fürst, R. Kneidinger, M. Schuller, B. Rupp, A. Banerjee, and H. Redl Expression and purification of biologically active rat bone morphogenetic protein-4 produced as inclusion bodies in recombinant Escherichia coli Biotechnol. Lett. 27 2005 1559 1564 (Pubitemid 41504246)
22. Q. Lu, M.C. Burns, P.J. McDevitt, T.L. Graham, A.J. Sukman, J.A. Fornwald, X. Tang, K.T. Gallagher, G.E. Hunsberger, J.J. Foley, D.B. Schmidt, J.J. Kerrigan, T.S. Lewis, R.S. Ames, and K.O. Johanson Optimized procedures for producing biologically active chemokines Protein Expr. Purif. 65 2009 251 260
23. J. Yang, W. Zhang, K. Liu, S. Jing, G. Guo, P. Luo, and Q. Zou Expression, purification, and characterization of recombinant human interleukin 24 in Escherichia coli Protein Expr. Purif. 53 2007 339 345 (Pubitemid 46453207)
24. L.F. Vallejo, and U. Rinas Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins Microb. Cell Fact. 3 2004 11 22
25. J. Hartman, P. Daram, R.A. Frizzell, T. Rado, D.J. Benos, and E.J. Sorscher Affinity purification of insoluble recombinant fusion proteins containing glutathione-S-transferase Biotechnol. Bioeng. 39 1992 828 832
26. M.R. Dyson, S.P. Shadbolt, K.J. Vincent, R.L. Perera, and J. McCafferty Production of soluble mammalian proteins in Escherichia coli: identification of protein features that correlate with successful expression BMC Biotechnol. 4 32 2004 1 17
27. D. Esposito, and D.K. Chatterjee Enhancement of soluble protein expression through the use of fusion tags Curr. Opin. Biotechnol. 17 2006 353 358 (Pubitemid 44163452)
28. R.L. Barker, G.J. Gleich, and L.R. Pease Acidic precursor revealed in human eosinophil granule major basic protein cDNA J. Exp. Med. 168 1988 1493 1498 (Pubitemid 18264882)
29. R.L. Barker, R.H. Gundel, G.J. Gleich, J.L. Checkel, D.A. Loegering, L.R. Pease, and K.J. Hamann Acidic polyamino acids inhibit human eosinophil granule major basic protein toxicity. Evidence of a functional role for ProMBP J. Clin. Invest. 88 1991 798 805
30. M. McGrogan, C. Simonsen, R. Scott, J. Griffith, N. Ellis, J. Kennedy, D. Campanelli, C. Nathan, and J. Gabay Isolation of a complementary DNA clone encoding a precursor to human eosinophil major basic protein J. Exp. Med. 168 1988 2295 2308 (Pubitemid 19020906)
31. P.C. Simons, and D.L.V. Jagt Purification of glutathione S-transferases from human liver by glutathione affinity chromatography Anal. Biochem. 82 1977 334 341 (Pubitemid 8194182)
32. R.G. DiScipio, and S. Pinz Sweeney The fractionation of human plasma proteins. II. The purification of human complement proteins C3, C3u and C5 by application of affinity chromatography Protein Expr. Purif. 5 1994 170 177
33. R.G. DiScipio, C.A. Smith, H.J. Muller-Eberhard, and T.E. Hugli The activation of human complement component C5 by a fluid phase C5 convertase J. Biol. Chem. 258 1983 10629 10636 (Pubitemid 14244323)
34. R.G. DiScipio, M.A. Hermodson, S.G. Yates, and E.W. Davie A comparison of human prothrombin factor IX (Christmas factor), factor X (Stuart factor), and protein S Biochemistry 16 1978 698 706
35. R.G. DiScipio, M.A. Hermodson, and E.W. Davie Activation of human factor X (Stuart factor) by a protease from Russell's viper venom Biochemistry 16 1977 5253 5260 (Pubitemid 8241844)
36. I. Schraufstatter, H. Takamori, L. Sikora, P. Sriramarao, and R.G. DiScipio Eosinophils and monocytes produce pulmonary and activation regulated chemokine, which activates cultured monocytes/macrophages Am. J. Physiol. Lung Cell. Molec. Physiol. 286 2004 L494-L501 (Pubitemid 38233619)
37. K. Vosbeck, P. Tobias, H. Mueller, R.A. Allen, K.E. Arfors, R.J. Ulevich, and L.A. Sklar Priming of polymorphonuclear granulocytes by lipopolysaccharides and its complexes with lipopolysaccharide binding protein and high density lipoprotein J. Leukoc. Biol. 47 1990 97 104 (Pubitemid 20061661)
38. I.U. Schraufstatter, R.G. Discipio, M. Zhao, and S.K. Khaldoyanidi C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation J. Immunol. 182 2009 3827 3836
39. A. Traynor-Kaplan, B. Thompson, A. Harris, P.M. Taylor, G.M. Omann, and L. Sklar Transient increase in phosphatidylinositol 3,4 biphosphate and phosphoinositol triphosphate during activation of human neutrophils J. Biol. Chem. 264 1989 32522 32527
40. 2 release by human blood monocytes and mouse peritoneal macrophages J. Immunol. Methods 78 1985 323 336 (Pubitemid 15109191)
41. M. Zhao, A. Wimmer, K. Trieu, R.G. DiScipio, and I.U. Schraufstatter Arrestin regulates MAPK activation and prevents NADPH oxidase-dependent death of cells expressing CXCR2 J. Biol. Chem. 279 2004 49259 49267 (Pubitemid 39625811)
42. H.A. Goldberg, and K.J. Warner The staining of acidic proteins on polyacrylamide gels: enhanced sensitivity and stability of "Stains- all" staining in combination with silver nitrate Anal. Biochem. 251 1997 227 233 (Pubitemid 27392682)
43. T.E. Hugli Biochemistry and biology of anaphylatoxins Complement 3 1986 111 127 (Pubitemid 17208216)
44. R.F. Guo, and P.A. Ward Role of C5a in inflammatory responses Annu. Rev. Immunol. 23 2005 821 852 (Pubitemid 40563186)
45. J. Kohl Anaphylatoxins and infectious and non-infectious inflammatory diseases Mol. Immunol. 38 2001 175 187 (Pubitemid 32786775)
46. R.G. DiScipio, and I.U. Schraufstatter The role of the complement anaphylatoxins in the recruitment of eosinophils Int. Immunopharmacol. 7 2007 1909 1923 (Pubitemid 350138516)
47. H.N. Fernandez, P.M. Henson, A. Otani, and T.E. Hugli Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under simulated in vivo conditions J. Immunol. 120 1978 109 115 (Pubitemid 8253794)
48. A.R. Johnson, T.E. Hugli, and H.J. Muller-Eberhard Release of histamine from rat mast cells by the complement peptides C3a and C5a Immunology 28 1975 1067
49. J. Furlong, M. Meighan, J. Conner, J. Murray, and J.B. Clements Methods for improved protein expression using pET vectors Nucleic Acids Res. 20 1992 4668
50. K. Hieshima, T. Imai, M. Baba, K. Shoudai, K. Ishizuka, T. Nakagawa, J. Tsuruta, M. Takeya, Y. Sakaki, K. Takatsuki, R. Miura, G. Opdenakker, J. Van Damme, O. Yoshie, and H. Nomiyama A novel human CC chemokine PARC that is most homologous to macrophage inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes J. Immunol. 159 1997 1140 1149 (Pubitemid 127484089)
51. M. Vulcano, S. Struyf, P.C. Scapini, M.S. Bernasconi, R. Bonecchi, A. Calleri, G. Penna, L. Adorini, W. Luini, A. Mantovani, J. Van Damme, and S. Sozzani Unique regulation of CCL18 production by maturing dendritic cells J. Immunol. 170 2003 3843 3849 (Pubitemid 36359255)
52. M. Allouche, and A. Bikfalvi The role of fibroblast growth factor-2 (FGF-2) in hematopoiesis Prog. Growth Factor Res. 6 1995 35 48 (Pubitemid 2617292)
53. M. Okada-Ban, J.P. Thiery, and J. Jouanneau Fibroblast growth factor-2 Int. J. Biochem. Cell Biol. 32 2000 263 267 (Pubitemid 30069969)
54. M.E. Levenstein, T.E. Ludwig, R.-H. Xu, R.A. Llanas, K. VanDenHeuvel-Kramer, D. Manning, and J.A. Thomson Basic FGF Support of Human Embryonic Stem Cell Self-Renewal Stem Cells 24 2006 568 574 (Pubitemid 44464760)
55. J.V. Frangioni, and B.G. Neel Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins Anal. Biochem. 210 1993 179 187 (Pubitemid 23147952)
56. P.H. Patterson Leukemia inhibitory factor, a cytokine at the interface between neurobiology and immunology Proc. Natl. Acad. Sci. USA 91 1994 7833 7835 (Pubitemid 24253838)
57. Z. Estrov, B. Samal, R. Lapushin, P. Kellokumpu-Lehtinen, A.A. Sahin, R. Kurzrock, M. Talpaz, and B.B. Aggarwal Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferation J. Interferon Cytokine Res. 15 1995 905 913
58. P.C. Heinrich, I. Behrmann, S. Haan, H.M. Hermanns, G. Müller-Newen, and F. Schaper Principles of interleukin (IL)-6-type cytokine signalling and its regulation Biochem. J. 374 Pt 1 2003 1 20 (Pubitemid 37046923)
59. C.A. Galloway, M.P. Sowden, and H.C. Smith Increasing the yield of soluble recombinant protein expressed in E. coli by induction during late log phase BioTechniques 34 2003 524 530 (Pubitemid 36298177)
60. A. Sivashanmugam, V. Murray, C. Cui, Y. Zhang, J. Wang, and Q. Li Practical protocols for production of very high yields of recombinant proteins using Escherichia coli Protein Sci. 18 2009 936 948